Qlaira
Qlaira is a medicine authorised by Swissmedic under authorisation number 58858. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 September 2009 and the authorisation is valid without a time limit. ATC code G03AB08 places the medicine in the group Sex hormones and modulators of the genital system.
| Authorisation number | 58858 |
|---|---|
| Name | Qlaira |
| Full name | Qlaira, Filmtabletten |
| Authorisation holder | Bayer (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G03AB08 |
| First authorisation | 17 September 2009 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Qlaira, Filmtabletten | B | 17 September 2009 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 28 | Dragée(s) | G03AB08 | 09.02.1. | B |
| 2 | 3 x 28 | Dragée(s) | G03AB08 | 09.02.1. | B |
| 3 | 6 x 28 | Dragée(s) | G03AB08 | 09.02.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Qlaira authorised in Switzerland?
Yes. Qlaira is authorised by Swissmedic under authorisation number 58858, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Qlaira have?
Qlaira is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Qlaira?
The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.